Miaoshou Doctor, a Chinese online healthcare services platform, has raised RMB600 million ($85 million) in the first tranche of Series D funding round backed by the likes of Qiming Venture Partners, Sequoia Capital China, Ince Capital Partners, CITIC Securities, and Index Capital.
The company achieved unicorn status with a post-deal valuation of more than RMB7 billion after an extended Series C round in June 2019. That followed an RMB500 million investment in January of the same...
Meishubao, China’s leading online art education platform, has raised $40 million in an extended Series C round led by Tencent Holdings.
Kuaidian, a Chinese interactive content provider, has raised close to $100 million in Series C funding led by Sequoia Capital China. Existing investors GGV Capital and Morningside Venture Capital re-upped.
Warburg Pincus will sell an approximately 5.5% interest in Hong Kong-listed IVF services provider Jinxin Fertility for about HK$1.5 billion ($194 million) through a share placement.
CLSA, the international arm of China-based brokerage CITIC Securities, has launched a strategy to offer high net worth clients investment opportunities in late-stage private companies in Asia.